NCT06888479View on ClinicalTrials.gov

Optimal Timing of Hepatitis B Vaccination After Transplants

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

March 1, 2029

Conditions
Transplant-Related DisorderHepatitis B Virus InfectionVaccine Reaction
Interventions
BIOLOGICAL

hepatitis B vaccine

Three doses of hepatitis B vaccine

Trial Locations (1)

300020

Institute of Hematology & Blood Diseases Hospital, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER